The 85th Scientific Sessions of the American Diabetes Association® (ADA) will be four days of education and engagement surrounding the latest advancements in diabetes research, care, and prevention.
The world’s largest diabetes conference will take place June 20–23 at the McCormick Place Convention Center in Chicago. Registration is underway, and advance registration rates are available through May 8.
“The ADA’s Scientific Sessions showcases the full spectrum of diabetes science, from fundamental discoveries to preclinical research, clinical trials, and emerging therapies and technologies,” said Marlon Pragnell, PhD, the ADA’s Vice President of Research and Science. “It’s thrilling to see new ideas emerge—how groundbreaking research presented in the session rooms and Poster Hall can progress to clinical studies and ultimately become therapeutic interventions that improve lives. Many of these life-changing innovations are on display in the Exhibit Hall, where attendees can see firsthand how science translates into real-world solutions.
“Attendees can dive deep into their areas of expertise while also gaining valuable insights across disciplines, broadening their understanding of the latest advances in diabetes research and care. With dynamic discussions spanning fundamental science to late-breaking clinical trials, this meeting is an unparalleled opportunity to connect, learn, and help drive what’s next in diabetes,” Dr. Pragnell continued.
Several symposia will highlight late-breaking clinical trial data. Each session is 90 minutes.
- Friday, 3:45 p.m. — PATHWEIGH Trial—Building the Highway for Weight Management in Primary Care
- Saturday, 8:00 a.m. — Emerging Non-Peptide, Small Molecule GLP-1 Receptor Agonists—Can They Become Players?
- Sunday, 8:00 a.m. — Efficacy and Safety of CagriSema 2.4mg/2.4mg in Adults with Overweight/Obesity—The REDEFINE 1 and REDEFINE 2 Clinical Trials
- Sunday, 1:30 p.m. — Advancing and Facilitating Basal Insulin Therapy in Type 2 Diabetes—Breaking News on the QWINT 1, 3, and 4 Trials with Once-Weekly Insulin Efsitora Alfa!
- Sunday, 4:30 p.m. — SOUL Trial—Effects of Oral Semaglutide on Cardiovascular (and Other) Outcomes in People with Type 2 Diabetes at High CV Risk
- Monday, 8:00 a.m. — Can We Improve the Quality of Weight Loss by Augmenting Fat Mass Loss while Preserving Lean Mass? The BELIEVE Study of Bimagrumab + Semaglutide
- Monday, 3:15 p.m. — Treatment of Hypercortisolism in People with Difficult-to-Control Type 2 Diabetes—Final Results of the CATALYST Trial
“We’re prioritizing engagement and question-and-answer time, making sure that at all the symposia people are strongly encouraged to ask questions, because that’s a major part of creating a great learning experience.”
– Marlon Pragnell, PhD
ADA Vice President of Research and Science
On-demand-only, as well as one-day in-person registration options also are available. On-site registration will open on Thursday, June 19, with final registration closing on June 23. Additional registration details are available on the ADA’s website.
The entire conference—scientific symposia, panel discussions, debates, Ask the Expert sessions, and more—will be presented in person, with no livestreamed sessions. On-demand access to recorded presentations will be available to registered participants following the conclusion of the Scientific Sessions, from June 25–August 25.
Register Today for the 85th Scientific Sessions
Join us in Chicago for the 85th Scientific Sessions, June 20–23, to learn about the latest advances in diabetes research, prevention, and care. Full in-person registration includes access to all of the valuable onsite content during the meeting and on-demand access to session recordings June 25–August 25.